2 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Resolution Therapeutics Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver | Phase 1 / Phase 2 | Active not recruiting | Resolution Therapeutics Limited | 30 | 2024-10-15 | 2026-10-05 |
| Study in Patients With Decompensated Liver Cirrhosis Liver Cirrhosis | Active not recruiting | Resolution Therapeutics Limited | 24 | 2023-10-10 | 2026-01-29 |
End Stage Liver Disease (2) · Hepatic Encephalopathy (2) · Liver Cirrhosis (2) · Fibrosis (1) · Jaundice (1) · Liver Diseases (1)
Spain (2) · United Kingdom (2)